Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/21/2013 | 11:03am CEST

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

jbaj@ptcbio.com

Sheryl Seapy

Pure Communications

sheryl@purecommunicationsinc.com


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
06:58a ROYAL THAI GOVERNMENT : Over 6 million people benefited from Government’s grassroots economy reinforcement policy
06:58a HUBER+SUHNER : Net sales grows significantly in the first half year 2016 – pleasing development of profitability
06:53a SHEFFIELD RESOURCES : 29 August 2016 Appendix 3Y
06:53a MARKETS AND MARKETS : Southeast Asia Waterproofing Systems Market worth 5.35 Billion USD by 2021
06:53a “PAKISTAN HAS RECOVERED ITS COTTON LOSSES FROM LAST YEAR AND EXPECTED TO ACHIEVE APPROXIMATELY 13 MILLION BALES OF COTTON IN THE COMING SEASON” ISLAMABAD : August 29, 2016
06:53a MITSUBISHI HEAVY INDUSTRIES : Regional Jet's flight to U.S. eyed for late Sept.
06:52a TOYOTA MOTOR : Announces Results for July 2016
06:48a SIEMENS : Healthineers presents imaging for complex, minimally invasive procedures
06:48a BRAHIM BERHAD : Quarterly rpt on consolidated results for the financial period ended 30 Jun 2016
06:46a TECH MAHINDRA : Saral Rozgar to Make 'Saral Rozgar Cards Online' Global, Eyes 100 Million Users
Latest news
Advertisement
Hot News 
-0.03%Crude Oil Prices Sink to Range Floor on Cooling OPEC Deal Hopes
0.38%Oil Prices Edge Up but Excess Supply Pressure Persists
Most Read News
08/29DJYAHOO : FBI Warns of Cyberattacks on Voter Records
08/29 Mondelez abandons pursuit of U.S. chocolate maker Hershey
08/29 AMERICAN AIRLINES : United Airlines hires No. 2 at American to be its president
08/29DJALPHABET : Executive Leaves Uber Board
08/29 APOLLO GLOBAL MANAGEMENT LLC : In twist, Caesars wins brief extension on lawsuit shield
Most recommended articles
12:05aDJTOKYO ELECTRIC POWER : Japan Braced for Typhoon Lionrock
08/30 OOH!MEDIA (ASX : OML) talks 1H 2016 results
08/30 Slowing U.K. Mortgage Applications to Stoke Larger GBP/USD Pullback
08/29DJOil Prices Edge Up but Excess Supply Pressure Persists
08/29DJASIA MARKETS : Asian Markets Get A Lift From U.S. Stock Gains